StreetInsider.com News Articles

SIGA to Host Business Update Call on November 9, 2026, Following Release of Third-Quarter 2026 Financial Results

Thu, 29 Oct 2026 07:30:00 -0400

NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Monday, November 9, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.

A live webcast of the call will also be available on the Company's website at http://www.siga.com in the Investor Relations section of the site, or by clicking here. Please log

SIGA to Host Business Update Call on November 9, 2026, Following Release of Third-Quarter 2026 Financial Results

Thu, 29 Oct 2026 07:30:00 -0400

A live webcast of the call will also be available on the Company's website at http://www.siga.com in the Investor Relations section of the site, or by clicking here. Please log

SIGA wins $15M Canada defence contract for smallpox antiviral TPOXX

Wed, 28 Oct 2026 07:30:23 -0400

SIGA Technologies, Inc. (Nasdaq: SIGA) announced that Public Services and Procurement Canada (PSPC) has awarded the company a contract valued at up to approximately $15 million for the supply of oral TPOXX® (tecovirimat) to the Canadian Department of National Defence (CDND).

The contract runs through March 31, 2031, with approximately $9 million representing firm commitments over the first three years. The remaining approximately $6 million is contingent on option exercises by the CDND. The procurement is made through the CDND's Strategic Medical Countermeasures Program.

This is the second contract PSPC has awarded on behalf of the CDND for oral TPOXX®. The first,

SIGA Secures Contract Valued at Up to $15 Million from Canadian Department of National Defence to Purchase TPOXX®

Wed, 28 Oct 2026 07:30:00 -0400

Continues Canada's commitment to smallpox preparedness for the Canadian Armed Forces

NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that Public Services and Procurement Canada (PSPC) has awarded SIGA a new contract for the procurement of oral TPOXX® (tecovirimat), an antiviral medication used to treat smallpox, on behalf of the Canadian Department of National Defence (CDND) through its Strategic Medical Countermeasures Program. The contract provides for the purchase of up to approximately $15 million by March 31, 2031, of which approximately $9 million represents firm commitments over

SIGA Secures Contract Valued at Up to $15 Million from Canadian Department of National Defence to Purchase TPOXX®

Wed, 28 Oct 2026 07:30:00 -0400

Continues Canada's commitment to smallpox preparedness for the Canadian Armed Forces

Trump On Plague: Looking At It Very Strongly - Bloomberg

Mon, 05 Oct 2026 15:29:21 -0400

Trump On Plague: Looking At It Very Strongly

Trump On Russia, Plague: We'll Help Them
Trump On Russia, Plague: We Just Heard About It

Trump On Plague: Looking At It Very Strongly - Bloomberg

Mon, 05 Oct 2026 15:29:21 -0400

Trump On Plague: Looking At It Very Strongly

Trump On Russia, Plague: We'll Help Them
Trump On Russia, Plague: We Just Heard About It

Rubio urges calm as U.S. tracks suspected pneumonic plague death at Russian lab

Mon, 05 Oct 2026 10:33:16 -0400

Investing.com -- U.S. Secretary of State Marco Rubio and the State Department are closely monitoring a suspected pneumonic plague outbreak in Siberia following the death of a Russian laboratory researcher, balancing calls for Moscow’s transparency with measured reassurances to the public.

Speaking to reporters Monday before departing for a diplomatic trip to Europe, Secretary Rubio addressed the fatal incident at the Irkutsk Anti-Plague Research Institute. "We’re watching and monitoring it closely," Rubio stated. "I don’t think it’s cause for alarm". The State Department backed his remarks with a formal statement confirming coordination with the Centers for Disease

Rubio urges calm as U.S. tracks suspected pneumonic plague death at Russian lab

Mon, 05 Oct 2026 10:33:16 -0400

Rubio urges calm as U.S. tracks suspected pneumonic plague death at Russian lab

Mon, 05 Oct 2026 10:33:16 -0400

Rubio urges calm as U.S. tracks suspected pneumonic plague death at Russian lab

Mon, 05 Oct 2026 10:33:16 -0400

Form 10-Q SIGA TECHNOLOGIES INC For: Jun 30

Tue, 11 Aug 2026 10:26:00 -0400

si-local-file:///var/storage/secattach/20260811/26903406.html

Form 10-Q SIGA TECHNOLOGIES INC For: Jun 30

Tue, 11 Aug 2026 10:26:00 -0400

si-local-file:///var/storage/secattach/20260811/26903406.html

Form 10-Q SIGA TECHNOLOGIES INC For: Jun 30

Thu, 06 Aug 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260806/26885074.html

Form 10-Q SIGA TECHNOLOGIES INC For: Jun 30

Thu, 06 Aug 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260806/26885074.html

SIGA Technologies, Inc. (SIGA) Reports Q2 EPS of $0.17

Thu, 06 Aug 2026 16:20:27 -0400

SIGA Technologies, Inc. (NASDAQ: SIGA) reported Q2 EPS of $0.17. Revenue for the quarter came in at $41 million.

For earnings history and earnings-related data on SIGA Technologies, Inc. (SIGA) click here.

Form 8-K SIGA TECHNOLOGIES INC For: Aug 06

Thu, 06 Aug 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260806/26883754.html

Form 8-K SIGA TECHNOLOGIES INC For: Aug 06

Thu, 06 Aug 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260806/26883754.html

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2026

Thu, 06 Aug 2026 16:01:00 -0400

$37 Million of TPOXX Sales Generated in the Second Quarter
Corporate Update Conference Call Today at 4:30 PM ET

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and six months ended June 30, 2026.

“In the second quarter, we delivered approximately $37 million of TPOXX to three customers: $24 million of IV TPOXX to the U.S. strategic national stockpile and $13 million of oral TPOXX to two international customers,” stated Diem Nguyen, Chief Executive Officer. “With

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2026

Thu, 06 Aug 2026 16:01:00 -0400

$37 Million of TPOXX Sales Generated in the Second Quarter
Corporate Update Conference Call Today at 4:30 PM ET

SIGA to Host Business Update Call on August 6, 2026, Following Release of Second-Quarter 2026 Financial Results

Thu, 30 Jul 2026 07:30:00 -0400

NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, August 6, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.

A live webcast of the call will also be available on the Company's website at http://www.siga.com in the Investor Relations section of the site, or by clicking here. Please log in

SIGA to Host Business Update Call on August 6, 2026, Following Release of Second-Quarter 2026 Financial Results

Thu, 30 Jul 2026 07:30:00 -0400

A live webcast of the call will also be available on the Company's website at http://www.siga.com in the Investor Relations section of the site, or by clicking here. Please log in

Form S-8 SIGA TECHNOLOGIES INC

Thu, 25 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260625/26692326.html

Form S-8 SIGA TECHNOLOGIES INC

Thu, 25 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260625/26692326.html

Form 4 SIGA TECHNOLOGIES INC For: Jun 09 Filed by: Marshall Joseph W III

Wed, 10 Jun 2026 21:33:00 -0400

si-local-file:///var/storage/secattach/20260610/26631407.html